Serial entrepreneur Eric Lefkofsky’s latest entrepreneurial adventure, Tempus Labs, was reviewed in the Release Fact’s article “Eric Lefkofksy’s Tempus Labs Uses Big Data Analytics to Revolutionize Cancer Medicine”. The article describes the company’s recent technology improvements that have been approved by the FDA that may have an impact on several serious diseases.
Tempus Labs has had a quick rise to the top, having an estimated worth of nearly $700 million dollars. The company has also been revealed as one of the top biotech health startups in the country, despite only being around for three years.
The company is dedicated to providing precision medicine for cancer patients. In partnership with cancer centers around the country, Tempus Labs has created a library of data, using molecular and clinical data to help physicians find the right treatment for the individual’s tumor and molecular structure.
The library composes clinical records, radiology scans, and even pathology images of patients who have suffered similar cancer and have similar genomic structures to create therapeutic and outcome data for each patient, in real-time.
The company’s machine learning and AI programs have also created improvements in a variety of health concerns. One such algorithm can identify skin cancer as well as a physician can, identifying both benign and malignant cancer cells. Others use technology like smartphones or watches to monitor glucose and directly provide insulin without a fingerstick calibration. Another monitors blood pressure through smartwatches and monitoring the radial artery. It also provides AI tech to monitor the eye and identify diseases like diabetic retinopathy.
Created in 2015, Tempus Labs sought to bring together all the disparate data from a variety of research universities and cancer treatment centers. They use data to help physicians find the best method of treatment while using genome sequencing to determine which treatment would work best for the individual.
Co-founded by Eric Lefkofsky, Tempus Labs has recently been featured as a revolutionary medicine technology by Dr. Eric Topol. Eric Lefkofsky has co-founded a variety of other companies like Groupon and Uptake. He also founded the Lefkofsky Family Foundation in partnership with his wife to provide initiatives in education, medicine, art, and culture.
For More info: www.lightbank.com/team/eric-lefkofsky